Search for "" - Xconomy

Entry	Author	Date	Location
Silence Therapeutics Taps Orchard’s Mark Rothera as President & CEO	Frank Vinluan	09/14/20	Europe
Synlogic Names Metera’s David Hava as Chief Scientific Officer	Frank Vinluan	09/14/20	Boston
Agios Exec Andrew Hirsch Jumps to C4 Therapeutics for CEO Role	Frank Vinluan	09/08/20	Boston
AlloVir Taps Merck’s Atillasoy as Chief Regulatory & Safety Officer	Frank Vinluan	09/08/20	Boston
Kura Oncology Adds Kyowa Kirin’s Stephen Dale as Chief Medical Officer	Sarah de Crescenzo	08/25/20	San Diego
Kronos Bio Names Yasir Al-Wakeel as Its First Chief Financial Officer	Sarah de Crescenzo	08/19/20	San Francisco
Fate Therapeutics Taps Celgene’s Dulac as Its Chief Financial Officer	Sarah de Crescenzo	08/19/20	San Diego
Sorrento Therapeutics Cuts Ties With Chief Financial Officer Jiong Shao	Sarah de Crescenzo	08/19/20	San Diego
Axovant’s Paul Korner Named Chief Medical Officer of Agile Therapeutics	Frank Vinluan	08/18/20	New York
MeiraGTx Names Immunovant’s Zeldin as Its Chief Medical Officer	Sarah de Crescenzo	08/05/20	New York
Page 1 of 101	next page »

Underwriters and Partners

Xconomy Insight

Sponsored · Video
The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!